Ondansetron hydrochloride injection is pleased to select the seventh batch of national centralized p2023-06-16
Ondansetron is a selective 5-HT3 receptor antagonist, which can effectively suppress or relieve nausea and vomiting caused by cytotoxic chemotherapy drugs and radiotherapy. Ondansetron has a rapid and powerful inhibitory effect on vomiting caused by some strong emetic chemotherapy drugs (such as cisplatin, cyclophosphamide, etc.).
Fluvastatin sodium sustained-release tablets received marketing approval from the State Drug Adminis2023-06-16
Fluvastatin is A hydroxymethylglutaryl-Coenzyme A (HMG-CoA) reductase suppressant for patients with primary hypercholesterolemia and mixed dyslipidemia (FredricksonⅡa and Ⅱb types) that is not fully controlled by diet.